STING1 and non-small cell lung carcinoma: By investigating suitable approaches to activate the STING pathway, it is possible to widely activate STING in chemotherapy, radiotherapy, molecularly targeted therapies, and immunotherapy for NSCLC therapy with its strong anti-tumor effect.